Spotlight on Our OARSI Congress Poster

We were honored to participate in the Osteoarthritis Research Society International (OARSI) Congress in Incheon, South Korea, from April 24 – 27!

🗣️ Clinical Trial Symposium
During the symposium, Professor Francis Berenbaum delivered an oral presentation on the clinical development pathway of intra-articular liraglutide, spotlighting the design of our upcoming Phase 2a proof-of-concept trial, INFLAM MOTION.

📊 Congress Poster Session
In a separate poster session, we presented:
“Intra-Articular Administration of Liraglutide for Cartilage Regeneration in Osteoarthritis: In vitro and In vivo Evidence of Pro-Chondrogenic Potential.”
This presentation underlines the promising pro-chondrogenic properties of intra-articular liraglutide and its potential to drive cartilage regeneration in osteoarthritis.